This is the authors' abstract. We don't add key points for this paper.
Radiotherapy resistance remains a major challenge in colorectal cancer (CRC), necessitating strategies that not only enhance radiosensitivity but also enable real-time monitoring of treatment-associated biological responses. Here, we present an integrated systems-level framework combining network pharmacology, in silico target analysis, in vitro validation, and dynamic volatolomic profiling to investigate metabolic adaptations associated with curcumin-mediated radiosensitization. Network-based analyses identified curcumin as a multi-target modulator of key radiation-response pathways, including PI3K/Akt, EGFR, STAT3, and apoptosis-related signaling. Functional validation in Caco-2 cells demonstrated enhanced radiosensitivity following curcumin treatment, evidenced by increased radiation-induced cytotoxicity and apoptosis, together with reduced clonogenic survival and migratory capacity. Dynamic volatolomic profiling using an electronic nose (eNose) revealed that treatment-associated metabolic changes could be continuously monitored through volatile organic compound (VOC) emissions. Time-resolved trajectory analysis, vector-field modeling, Hidden Markov Model state inference, and Markov transition analysis demonstrated that VOC signatures encode dynamic metabolic-state evolution and probabilistic state transitions during treatment response. Curcumin reduced baseline VOC emissions, whereas irradiation induced dose-dependent metabolic perturbations associated with nonlinear VOC trajectories. Combined treatment generated distinct state-dependent VOC signatures consistent with enhanced metabolic reprogramming during radiosensitization. By integrating molecular signaling, cellular phenotypes, and dynamic VOC outputs, this study extends volatolomics beyond conventional classification-based applications and establishes a systems-level framework for monitoring treatment-induced metabolic-state transitions. These findings support the potential of eNose-based volatolomics as a non-invasive platform for real-time assessment of radiosensitization and therapeutic response in CRC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: